Hoge Stephen's Form 4 filing
Moderna, Inc.MRNA · filed Oct 16, 2026
- Accession no.
- 0001682852-26-000187
- Filed
- Oct 16, 2026, 4:09 PM ET
- Trade date
- Oct 14-15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 2 derivative transactions. Open-market sales total $17.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoge StephenCIK 0001760669 | Officer (President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Common Stock | MOption exerciseAcquired | +76,453 | $12.21 | +$933,491.13 | 1,638,482 | Direct | |
| Oct 14, 2026 | Common Stock | SSaleDisposed | −38,774 | $213.47F2 | −$8,277,085.78 | 1,599,708 | Direct | |
| Oct 14, 2026 | Common Stock | SSaleDisposed | −450 | $214.15F3 | −$96,367.5 | 1,599,258 | Direct | |
| Oct 15, 2026 | Common Stock | MOption exerciseAcquired | +76,452 | $12.21 | +$933,478.92 | 1,675,710 | Direct | |
| Oct 15, 2026 | Common Stock | SSaleDisposed | −39,145 | $220.72F4 | −$8,640,084.4 | 1,636,565 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | Common Stock | MOption exerciseDisposed | −76,453 | $0.00 | $0 | 229,357 | Direct | |
| Oct 15, 2026 | Common Stock | MOption exerciseDisposed | −76,452 | $0.00 | $0 | 152,905 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $213.03 to $213.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $214.05 to $214.37. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $220.60 to $221.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.